BDBM331928 (2S)-1-(6-(5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)-1,6-diazaspiro[3.5]nonan-1-yl)-3-methoxypropan-2-ol::US10189859, Compound 161

SMILES COC[C@@H](O)CN1CCC12CCCN(c1nnc(-c3cccc(Cl)c3Cl)c(N)n1)C2

InChI Key InChIKey=DGWCLSOPVZFHPD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 331928   

TargetSodium channel protein type 9 subunit alpha(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 331928BDBM331928(US10189859, Compound 161 | (2S)-1-(6-(5-amino-6-(2...)
Affinity DataIC50: 5.14E+4nMAssay Description:The potencies of the compounds provided herein to block specific Na+ channels was measured using automated patch clamp electrophysiologically of Nav1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 331928BDBM331928(US10189859, Compound 161 | (2S)-1-(6-(5-amino-6-(2...)
Affinity DataIC50: 1.47E+5nMAssay Description:The potencies of the compounds provided herein to block specific Na+ channels was measured using automated patch clamp electrophysiologically of Nav1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent